BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology
Yanna Zhao, Hongyan Zhou, Yan Zhao, Zhen Liang, Xiaokang Gong, Jing Yu, Tiantian Huang, Chaoqin Yang, Mengjuan Wu, Yifan Xiao, Youhua Yang, Wei Liu, Xiaochuan Wang, Xiji Shu, Jian Bao
Abstract
BACE1 is essential for the generation of amyloid-β (Aβ) that likely initiates the toxicity in Alzheimer's disease (AD). BACE1 activity is mainly regulated by post-translational modifications, but the relationship between these modifications is not fully characterized. Here, we studied the effects of BACE1 SUMOylation on its phosphorylation and ubiquitination. We demonstrate that SUMOylation of BACE1 inhibits its phosphorylation at S498 and its ubiquitination in vitro. Conversely, BACE1 phosphorylation at S498 suppresses its SUMOylation, which results in promoting BACE1 degradation in vitro. Furthermore, an increase in BACE1 SUMOylation is associated with the progression of AD pathology, while its phosphorylation and ubiquitination are decreased in an AD mouse model. Our findings suggest that BACE1 SUMOylation reciprocally influences its phosphorylation and competes against its ubiquitination, which might provide a new insight into the regulations of BACE1 activity and Aβ accumulation.